-
Uncategorized1 week agoSTAT+: Fatal gene-editing trial in China raises ethics and oversight questions
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Today, a win for RFK...
-
Uncategorized1 week ago
Lilly’s $3.8B psychedelics bet won’t open the M&A floodgates
Eli Lilly’s $3.8 billion play for AtaiBeckley has fueled speculation that Big Pharma is ready to embrace psychedelics. But while the acquisition does validate the drug...
-
Uncategorized1 week ago
Summit has less than a year of cash runway left as PD-1/VEGF verdict nears
Summit’s star asset is the PD-1/VEGF bispecific ivonescimab, which this week produced promising survival data from a late-stage global trial in non-small cell lung cancer. The...
-
Uncategorized1 week agoA new, separate outbreak of the diarrhea-causing parasite
Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here. Yesterday, my friend who lives in the Bay...
-
Uncategorized1 week agoSTAT+: Merck strikes voluntary licensing deals in poor countries for an experimental HIV prevention pill
Amid rising concern over efforts to contain HIV, Merck has reached voluntary licensing deals with seven companies to make generic versions of an experimental, once-a-month prevention...
-
Uncategorized1 week agoSenate advances MAHA-friendly bill for food warning labels and junk food ad bans
Amid debates over whether the political influence of the Make America Healthy Again movement is on the wane, a new bill advanced in the Senate on...
-
Uncategorized1 week agoOpinion: The U.S. pharmaceutical supply chain problem is not about China
In 2025, there were 216 active drug shortages in the U.S., impacting Americans’ access to lifesaving medications. The resilience of our pharmaceuticals supply chains has been...
-
Uncategorized1 week agoSingle-Cell Atlas Simultaneously Maps 3D Genome Architecture and DNA Methylation
Single-Cell Atlas Simultaneously Maps 3D Genome Architecture and DNA Methylation
-
Uncategorized1 week agoScribe secures $129M in a rare gene editing IPO
The startup is the first gene editing company to price an IPO in more than two years, though it banked far less than most other biotech...
-
Uncategorized1 week ago
Ferricyanide-mediated direct ligation of peptide hydrazides in neutral water
Post Content
